The long timelines, high attrition rates, and high costs of global health R&D are impeding the development of new medicines, vaccines, and diagnostics. The Center for Policy Impact in Global Health partnered with colleagues at Open Consultants, the University of KwaZulu-Natal, and Peking University to conduct two studies on reforming the global health R&D ecosystem. The studies focused on product development for neglected diseases, emerging infectious diseases, and maternal health.
Questions? Please contact Gavin Yamey.
To stay up to date on our work subscribe to our mailing list.